The Chest Pain And The Heart Attack.
For patients seen in predicament rooms solely for caddy pain, noninvasive screening tests may not always predict subsequent heart trouble, a new study suggests. Such tests include: electrocardiograms, which end the heart's electrical activity, echocardiograms, which measure how well blood is flowing in the heart using ultrasound, and CT scans of the heart. All three tests are recommended for strongbox pain under current guidelines, the investigation authors said ante health. "It may be safe to defer early cardiac stress testing in patients with box pain but no evidence of a heart attack," said lead researcher Dr Andrew Foy, an helper professor of medicine and public health sciences at the Penn State Milton S Hershey Medical Center in Hershey, PA.
Foy doesn't over these tests are overused, but may not be needed in all cases. "Furthermore, ahead cardiac stress testing appears to sequel in unnecessary, additional tests and invasive treatments". Around 6 million patients go to the pinch room with chest pain each year in the United States. "Therefore, these findings could impact the disquiet of a large number of patients hersolutiongel. Foy said that for patients with chest pain not brought on by a nitty-gritty attack, it seems safe to defer early cardiac stress tests.
So "We would vouch for they follow up closely with their primary care provider or cardiologist for the best advice on what to do after chest pain. If the torment returns, then cardiac stress testing may certainly be reasonable, depending on the nature of the pain and their other imperil factors for heart disease. The report was published online Jan 26, 2015 in the tabloid JAMA Internal Medicine. For the study, Foy and his colleagues used haleness insurance claims from a group of almost 700000 privately insured patients seen in emergency rooms for thorax pain in 2011.
From this group, they identified almost 422000 patients, of which more than 293000 did not receive noninvasive tests and stingy to 128000 did. The most common test used was a myocardial perfusion scintigraphy - a examination that shows blood flow in the heart. According to Foy, the percentage of patients hospitalized for a pump attack was only 0,11 percent a week after being seen in the emergency room and only 0,33 percent 190 days after being seen.
Patients who did not have prime noninvasive tests were no more likely to have a heart attack than those who did inherit testing, the researchers found. Patients who received these tests, however, were more likely to have invasive procedures such as angioplasty. Yet these procedures did not recuperate the odds against having a heart attack. In an editor's note that accompanied the study, Dr Rita Redberg, editor-in-chief of JAMA Internal Medicine, said such tests in low-risk patients are surplus and lengthen time spent in the ER. "It is occasion to change our guidelines and practice for treatment of chest pain in low-risk patients.
Such patients should be given a familiar follow-up appointment with a primary care physician who can determine, based on the patient's condition, whether further valuation is necessary". But Dr Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles, said since the go into researchers looked back at patients who went to the emergency room and used statistics from insurance companies, the true value of these tests can't be definitively determined toilet. Studies looking at patients in earnest time need to be done to identify the value of these tests for low-risk chest grief patients.
No comments:
Post a Comment